E21.1 Billable / specific Secondary hyperparathyroidism, not elsewhere classified
ICD-10-CM E21.1 identifies “Secondary hyperparathyroidism, not elsewhere classified” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Excludes 11
secondary hyperparathyroidism of renal origin (N25.81)
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E20-E35 · Disorders of other endocrine glands (E20-E35)
E21 · Hyperparathyroidism and other disorders of parathyroid gland
Excludes 14
Excludes 21
familial hypocalciuric hypercalcemia (E83.52)
Official index references
Official index references (2)
Hyperparathyroidism (1)
- Hyperparathyroidism › secondary(renal) › non-renalDisease index
Osteodystrophy (1)
- Osteodystrophy › parathyroid, secondaryDisease index
References from other codes (1)
Excludes 1 · secondary hyperparathyroidism, non-renal (E21.1)
History
Code history
Latest recorded change · FY2022
Effective from
- Inherited rules changed
Secondary hyperparathyroidism, not elsewhere classified
Billable diagnosis code
CDC/NCHS · FY2022All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Inherited rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 252.02
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.